Services of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Electron Microscopy Facility, University of Lausanne, Lausanne, Switzerland.
PLoS Pathog. 2022 Jul 5;18(7):e1010673. doi: 10.1371/journal.ppat.1010673. eCollection 2022 Jul.
The limited development of broadly neutralizing antibodies (BnAbs) during HIV infection is classically attributed to an inadequate B-cell help brought by functionally impaired T follicular helper (Tfh) cells. However, the determinants of Tfh-cell functional impairment and the signals contributing to this condition remain elusive. In the present study, we showed that PD-L1 is incorporated within HIV virions through an active mechanism involving p17 HIV matrix protein. We subsequently showed that in vitro produced PD-L1high but not PD-L1low HIV virions, significantly reduced Tfh-cell proliferation and IL-21 production, ultimately leading to a decreased of IgG1 secretion from GC B cells. Interestingly, Tfh-cell functions were fully restored in presence of anti-PD-L1/2 blocking mAbs treatment, demonstrating that the incorporated PD-L1 proteins were functionally active. Taken together, the present study unveils an immunovirological mechanism by which HIV specifically exploits the regulatory potential of PD-L1 to suppress the immune system during the course of HIV infection.
在 HIV 感染过程中,广泛中和抗体(BnAbs)的有限发展通常归因于功能失调的滤泡辅助性 T 细胞(Tfh)细胞提供的不足的 B 细胞辅助。然而,Tfh 细胞功能障碍的决定因素以及导致这种情况的信号仍然难以捉摸。在本研究中,我们表明 PD-L1 通过一种涉及 p17 HIV 基质蛋白的主动机制被包含在 HIV 病毒粒子中。随后,我们表明,体外产生的 PD-L1high 但不是 PD-L1low HIV 病毒粒子,显著降低了 Tfh 细胞的增殖和 IL-21 的产生,最终导致 GC B 细胞分泌的 IgG1 减少。有趣的是,在存在抗 PD-L1/2 阻断 mAbs 治疗的情况下,Tfh 细胞的功能得到完全恢复,表明包含的 PD-L1 蛋白具有功能活性。总之,本研究揭示了一种免疫病毒学机制,通过该机制,HIV 特异性利用 PD-L1 的调节潜力,在 HIV 感染过程中抑制免疫系统。